A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
സെൻസെക്സ്
74,003.82
▼ -1.04%
നിഫ്റ്റി
23,118.60
▼ -1.19%
സ്വർണ്ണം
₹ 14,039/gm
വെള്ളി
₹ 2,49,900/kg
പെട്രോൾ
₹ 115.49
ഡീസൽ
₹ 104.40
എൽപിജി
₹ 951.00
ക്രൂഡ് ഓയിൽ
$ 107.90
USD
₹ 95.93
സെൻസെക്സ്
74,003.82
▼ -1.04%
നിഫ്റ്റി
23,118.60
▼ -1.19%
സ്വർണ്ണം
₹ 14,039/gm
വെള്ളി
₹ 2,49,900/kg
പെട്രോൾ
₹ 115.49
ഡീസൽ
₹ 104.40
എൽപിജി
₹ 951.00
ക്രൂഡ് ഓയിൽ
$ 107.90
USD
₹ 95.93
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
77.10% ↑
NAV (₹) on 15 Sep 2026
40.06
1 Day NAV Change
-1.04%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
20 Jun 2019
Min. Lumpsum Amount
₹ 500
Fund Age
7 Yrs
AUM
₹ 1,102.73 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.02%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,102.73 Cr
Equity
96.37%
Money Market & Cash
3.85%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 72.76% |
| Hospitals & Medical Services | 20.88% |
| Treps/Reverse Repo | 3.85% |
| Chemicals - Speciality | 1.18% |
| Insurance Distributor | 0.78% |
| Chemicals - Organic - Benzene Based | 0.77% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | 9.57% | ₹ 105.51 | Pharmaceuticals |
| Sun Pharmaceutical Industries Ltd. | 9.19% | ₹ 101.39 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.85% | ₹ 75.58 | Hospitals & Medical Services |
| Cipla Ltd. | 5.16% | ₹ 56.95 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.53% | ₹ 50.01 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 4.22% | ₹ 46.58 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 4.20% | ₹ 46.31 | Pharmaceuticals |
| TREPS | 3.85% | ₹ 42.47 | Others |
| Mankind Pharma Ltd. | 3.41% | ₹ 37.64 | Pharmaceuticals |
| Lupin Ltd. | 3.10% | ₹ 34.19 | Pharmaceuticals |
| Abbott India Ltd. | 3.03% | ₹ 33.43 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd. | 2.99% | ₹ 32.98 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.79% | ₹ 30.74 | Hospitals & Medical Services |
| IPCA Laboratories Ltd. | 2.71% | ₹ 29.93 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.63% | ₹ 29.01 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 2.23% | ₹ 24.61 | Pharmaceuticals |
| Corona Remedies Ltd. | 2.17% | ₹ 23.98 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 2.10% | ₹ 23.17 | Hospitals & Medical Services |
| Thyrocare Technologies Ltd. | 1.94% | ₹ 21.43 | Hospitals & Medical Services |
| Procter & Gamble Health Ltd. | 1.84% | ₹ 20.30 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd. | 1.76% | ₹ 19.42 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 1.69% | ₹ 18.67 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 1.55% | ₹ 17.10 | Hospitals & Medical Services |
| Shilpa Medicare Ltd. | 1.27% | ₹ 13.95 | Pharmaceuticals |
| Piramal Pharma Ltd. | 1.24% | ₹ 13.68 | Pharmaceuticals |
| Biocon Ltd. | 1.19% | ₹ 13.07 | Pharmaceuticals |
| Pfizer Ltd. | 1.19% | ₹ 13.14 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd. | 1.18% | ₹ 13.07 | Chemicals - Speciality |
| Anthem Biosciences Ltd. | 1.15% | ₹ 12.65 | Pharmaceuticals |
| Manipal Health Enterprises Ltd | 1.12% | ₹ 12.39 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Ltd. | 1.08% | ₹ 11.88 | Hospitals & Medical Services |
| Dr. Reddy's Laboratories Ltd. | 1.04% | ₹ 11.43 | Pharmaceuticals |
| Suraksha Diagnostic Ltd. | 1.03% | ₹ 11.33 | Hospitals & Medical Services |
| Natco Pharma Ltd. | 0.92% | ₹ 10.10 | Pharmaceuticals |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.90% | ₹ 9.88 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd. | 0.78% | ₹ 8.61 | Insurance Distributor |
| Vinati Organics Ltd. | 0.77% | ₹ 8.51 | Chemicals - Organic - Benzene Based |
| Syngene International Ltd. | 0.69% | ₹ 7.58 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 0.66% | ₹ 7.29 | Hospitals & Medical Services |
| Jubilant Pharmova Ltd. | 0.50% | ₹ 5.56 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 17.93% | 16.45% | 6.76% | 20.99% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
Fund Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
AMC Details
Name
Aditya Birla Sun Life AMC Limited
Date of Incorporation
23 Dec 1994
CEO
Mr. A Balasubramanian
CIO
Type
Pvt.Sector-Joint Venture (Indian)
Address
One World Center, Tower 1, 17th Floor,
Jupiter Mills,
Senapati Bapat Marg,
Elphinstone Road, Mumbai, Maharashtra, India - 400013
Website
https://mutualfund.adityabirlacapital.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
Top Funds from Aditya Birla Sun Life AMC Limited
FAQs
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹40.06 as of 15 Sep 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹1,102.73 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth has delivered returns of 16.45% (1 Year), 20.99% (3 Year), 13.84% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+
X
